Literature DB >> 9737554

Population attributable risk of renal cell cancer in Minnesota.

J Benichou1, W H Chow, J K McLaughlin, J S Mandel, J F Fraumeni.   

Abstract

A population-based case-control study of renal cell cancer was conducted in Minnesota between 1988 and 1990. It included 690 histologically confirmed incident cases identified through the state cancer surveillance system, and 707 age and sex frequency-matched controls. In this paper, the authors present estimates of the proportion of renal cell cancer cases attributable (or population attributable risk (PAR)) to 1) well-established risk factors, namely smoking, excess weight, and hypertension, and 2) more speculative risk factors, namely elevated protein intake, history of renal disease (i.e., stone, injury, or infection) and high parity among women. These estimates were based on information obtained from directly interviewed subjects (65% of cases and 100% of controls). The PARs for the three main risk factors were 21% for hypertension (defined by a reported personal history of hypertension or of treatment with antihypertensive or diuretic drugs), 21% for excess weight (defined by an elevation of the usual body mass index above the first quartile), and 18% for smoking (past and current). Overall, these three factors accounted for 49% of cases. The proportion increased to 60% when the three more speculative risk factors were considered as well. Sex-specific analyses revealed a greater impact of smoking among men mainly due to a higher prevalence of past smoking. In contrast, the impact of hypertension and excess weight was greater among women due to higher relative risks. These results suggest that 1) intervention measures aimed at reducing smoking, excess weight, and hypertension could substantially lower the overall incidence of renal cell cancer, and 2) intervention measures may have to be sex-specific. Conversely, because at least 40% of cases remain unexplained by the risk factors under study, further etiologic research is needed into renal cell cancer, an increasingly common form of cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9737554     DOI: 10.1093/oxfordjournals.aje.a009667

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

1.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

2.  Hypertension and risk of renal cell carcinoma among white and black Americans.

Authors:  Joanne S Colt; Kendra Schwartz; Barry I Graubard; Faith Davis; Julie Ruterbusch; Ralph DiGaetano; Mark Purdue; Nathaniel Rothman; Sholom Wacholder; Wong-Ho Chow
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

3.  Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.

Authors:  Michele L Cote; Joanne S Colt; Kendra L Schwartz; Sholom Wacholder; Julie J Ruterbusch; Faith Davis; Mark Purdue; Barry I Graubard; Wong-Ho Chow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

4.  Fractions of cardiovascular diseases and mental disorders attributable to psychosocial work factors in 31 countries in Europe.

Authors:  Isabelle Niedhammer; Hélène Sultan-Taïeb; Jean-François Chastang; Greet Vermeylen; Agnès Parent-Thirion
Journal:  Int Arch Occup Environ Health       Date:  2013-04-27       Impact factor: 3.015

Review 5.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

6.  Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.

Authors:  Cheng-You Jia; Yu-Jin Liu; Xian-Ling Cong; Yu-Shui Ma; Ran Sun; Da Fu; Zhong-Wei Lv
Journal:  Tumour Biol       Date:  2013-12-15

7.  Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.

Authors:  S Karami; P Boffetta; N Rothman; R J Hung; T Stewart; D Zaridze; M Navritalova; D Mates; V Janout; H Kollarova; V Bencko; N Szeszenia-Dabrowska; I Holcatova; A Mukeria; J Gromiec; S J Chanock; P Brennan; W-H Chow; L E Moore
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

8.  Family history of cancer and renal cell cancer risk in Caucasians and African Americans.

Authors:  S Karami; K Schwartz; M P Purdue; F G Davis; J J Ruterbusch; S S Munuo; S Wacholder; B I Graubard; J S Colt; W-H Chow
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

9.  Clearing the Air: Summarizing the Smoking-related Relative Risks of Bladder and Kidney Cancer.

Authors:  Mark P Purdue; Debra T Silverman
Journal:  Eur Urol       Date:  2016-04-27       Impact factor: 20.096

10.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.